Compare INFU & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INFU | INGN |
|---|---|---|
| Founded | 2005 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.4M | 175.6M |
| IPO Year | 2005 | 2013 |
| Metric | INFU | INGN |
|---|---|---|
| Price | $9.79 | $6.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $15.00 | $11.00 |
| AVG Volume (30 Days) | 117.4K | ★ 292.9K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | 43.42 |
| EPS | ★ 0.31 | N/A |
| Revenue | $143,436,000.00 | ★ $348,668,000.00 |
| Revenue This Year | $2.89 | $7.92 |
| Revenue Next Year | $7.66 | $7.86 |
| P/E Ratio | $31.32 | ★ N/A |
| Revenue Growth | ★ 6.36 | 3.86 |
| 52 Week Low | $4.61 | $5.34 |
| 52 Week High | $11.04 | $9.13 |
| Indicator | INFU | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 59.48 | 55.54 |
| Support Level | $9.73 | $6.25 |
| Resistance Level | $9.83 | $6.83 |
| Average True Range (ATR) | 0.36 | 0.23 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 91.60 | 58.33 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.